Thursday, August 2, 2012

Metal on Metal Depuy Hip Implants Are Coming Apart and Dislocating in People by Texas Metal Failed Hip Implant Lawyer and DePuy ASR XL Failed Metal Hip Implant Lawyer

Metal on Metal Hip Implants Including Metal Depuy Hip Implants Are Coming Apart and Dislocating in People Causing the Need for Metal Hip Implant Replacement Surgery and Metal Hip Implant Revision Surgery by Texas Metal Failed Hip Implant Lawyer, Texas Hip Revision Surgery Lawyer, and Texas Failed Metal Hip Implant Lawyer Jason S. Coomer

Metal hip implant patients including people with DePuy ASR and DePuy ASR XL metal-on-metal hip implants have experienced release of metal debris from the metal hip implant as well as loosening and dislocation of the metal hip implant.  These metal on metal hip implant issues often require hip implant patients to require metal hip implant revision surgery or metal hip implant replacement surgery.  These hip replacement surgeries can often be more difficult to than the original hip replacement surgery and result in severe pain and disability.

Defective Hip Implant Devices Lead to Suffering Pain, Impairment, and Mental Anguish as well as having to have Hip Revision Surgery to Repair the Problem

Hip revision surgery is one of the most serious and prolonged injuries resulting from DePuy defective hip replacement systems and other metal on metal hip implants.  Metal hip revision surgery is the need for surgical extraction of a faulty metal on metal hip implant such as a DePuy ASR Hip Implant Device or DePuy ASR XL and replacement with another defect-free Hip Replacement System of proper design by other orthopedic device manufacturer. The metal on metal hip replacement by its very nature of necessity is often surgically performed in middle-aged and elderly population. And recovery from the second hip replacement is often more difficult than after the first. A second surgery of this nature could and often does increase the risk of complications, severe infections, prolonged recovery time, and death. In some patients the infection resulting from defective ASR system, is so advanced and systemic that a revision surgery is not possible. In this group of patients the only option is a surgical extraction of defected device without any corrective hip replacement to restore the lost mobility function patients experienced in first place.

After a person has gone through an extensive hip surgery including the lengthy recovery and process, it can be very upsetting to learn that the manufacturer incorrectly made the implant so that it will have to removed and the person will have to undergo the hip replacement surgery again requiring more recovery, missed time from work, and missed time from family and normal functioning.
Regardless, as to whether the failed hip replacement surgery is caused by  a defective Zimmer Cup, defective Trident Hemispherical Cup, defective Trident PSL Cup, defective DePuy Orthopaedics Inc. ASR Hip Resurfacing System, defective DePuy ASR XL Acetabular System, and/or medical negligence, it is important to understand the cause of a failed hip replacement surgery.

Hip Revision Surgery and Hip Replacement Surgery including Total Joint Hip Revision Surgery, Total Hip Replacement Surgery, Total Hip Arthroplasty, and other Hip Surgery

Hip replacement surgery, also called total hip arthroplasty, involves removing a diseased or broken hip joint and replacing it with an artificial joint, called a prosthesis. Hip prostheses commonly consist of a ball component, made of metal or ceramic, and a socket, which has an insert or liner made of plastic, ceramic or metal. The implants used in hip replacement are or should be biocompatible (meaning they're designed to be accepted by your body) and made to resist corrosion, degradation and wear. 

Hip replacement surgery is typically used for people with hip joint damage from arthritis or a serious injury.  Followed by rehabilitation, hip replacement surgery can relieve pain and restore range of motion and function of the hip joint.  However, it should be understood that Hip Replacement Surgery is an invasive and serious medical procedure that can be extremely hard on a person and will require significant time to recover.  It is important that a person seeking a hip replacement consult with one or more medical doctors that they trust to determine if they are healthy enough to undergo hip replacement surgery. 

As a total hip joint replacement replaces the ends of both bones in a damaged hip joint to create new joint surfaces and a total hip replacement surgery replaces the upper end of the thighbone (femur) with a metal ball and resurfaces the hip socket in the pelvic bone with a metal shell and plastic liner, it is essential that the hip implants are biocompatible and are correctly made to resist corrosion, degradation, and wear as well as to work well without rubbing. 

After a person has gone through an extensive hip surgery including the lengthy recovery and process, it can be very upsetting to learn that the manufacturer incorrectly made the implant so that it will have to removed and the person will have to undergo the hip replacement surgery again requiring more recovery, missed time from work, and missed time from family and normal functioning.


  Metal Hip Revision Surgery Lawsuits, DePuy Defective Hip Implant Lawsuits, Implantable Hip Failure Lawsuits, and Failed Hip Surgery Resulting in Permanent Disability and Paralysis Lawsuits  by Texas Failed Metal Hip Implant Lawyer, Jason Coomer 

Failed metal hip implants can cause severe pain, catastrophic injuries, physical impairment, and the need for additional hip replacement surgery.  There are several defective metal hip implants that can come apart or dislocate including Zimmer Cups, Trident Hemispherical Cups, Trident PSL Cups, DePuy ASR Hip Resurfacing Systems, and Depuy ASR XL Acetabular Systems.  

For more information on metal hip replacement surgery lawsuits or metal hip revision surgery lawsuits,  please go to the following Web Pages: Depuy Replacement Hip Surgery Lawsuit Information, Failed Hip Surgery Medical Malpractice Lawsuit & Defective Hip Implant Lawsuit Information, and Depuy Failed Hip Surgery Lawsuit and Metal on Metal Hip Implant Replacement Surgery Lawsuit Information.

Thursday, July 19, 2012

Diabetic Cancer Is On The Rise As Some Diabetes Drugs May Cause Diabetics to Develop Cancer by Texas Diabetic Cancer Lawyer, Diabetic Cancer Death Lawyer, Diabetic Pancreatic Cancer Lawyer and Diabetic Pancreas Cancer Lawyer Jason S. Coomer

  Diabetic Cancer Is On The Rise As Some Diabetes Drugs May Cause Pancreatic Cancer, Bladder Cancer, & other Forms of Deadly Cancer: Persons Taking Januvia, Victoza, Byetta, Janumet, Actos, and other Diabetes Drugs Should Be Aware of Potential Diabetic Cancer Dangers and Consult Their Physician Regarding Potential Pancreas Cancer Risks by Texas Diabetic Cancer Lawyer, Diabetic Cancer Death Lawyer, Diabetic Pancreatic Cancer Lawyer and Diabetic Pancreas Cancer Lawyer Jason S. Coomer


More than 300 million people worldwide suffer from diabetes, including about 30 million Americans.  In 2010, the global prevalence of diabetes was estimated to have reached 285 million and predicted to reach 438 million in 2030. The corresponding figures for North America were 37.4 million in 2010 and 53.2 million by 2030 and in Europe 55.2 million in 2010 and 66.2 million in 2030.  The global market for products in the management of diabetes currently stands at $41 billion and is on pace to grow to over $114 billion by 2018. 

With this huge demand for diabetic treatments have come the aggressive marketing of several diabetic drugs that have been shown to increase a diabetic's risk of cancer including pancreatic cancer, bladder cancer, and other types of cancer. Diabetics and their families should be aware of the potential danger of any diabetic drug.  Further, if a diabetic has been taking a diabetic drug and has been diagnosed with cancer, it is important to report the adverse event to their doctor and the FDA.

 Diabetic Drug Cancer Including Diabetic Pancreatic Cancer and Diabetic Bladder Cancer Needs to Be Reported to Deter Future Misleading Marketing and Distribution of Diabetes Drugs

Pancreatic cancer is the fourth leading cause of cancer death for both men and women and is one of the most deadly of all types of cancer. The diabetes drugs, Januvia, Byetta, Victoza, and Janumet, may cause an increased risk of pancreatic cancer in diabetic patients using the diabetes drugs.   The diabetes drug, Actos, may cause an increased risk of bladder cancer in diabetic patients using this diabetes drug.

If you have lost a loved one from diabetic drug cancer or have suffered acute pancreatitis, hemorrhagic pancreatitis, accute necrotizing pancreatitis, pancreas cancer, or bladder cancer; and have been using a diabetes drug, please report the adverse action to the prescribing medical doctor as soon as possible.  For more diabetic cancer lawsuit, diabetic cancer death lawsuit, or other defect drug cancer lawsuit information, please feel free to contact Diabetic Cancer Lawyer, Diabetic Cancer Death Lawyer, and Defective Drug Cancer Lawyer


 

Monday, July 9, 2012

Some Birth Control Medications Can Increase A Woman's Risk of a Heart Attack, Stroke, or Blood Clot Death by Birth Control Blood Clot Death Lawyer

The Multi-Billion Dollar Birth Control Market Includes Several Drug Companies That Are Aggressively Birth Control That Increased A Woman's Risk of a Heart Attack, Stroke, or Blood Clot Death: Women on These Danagerous Birth Control Medications Should be Adequately Warned of the Health Risk by Texas Birth Control Heart Attack Lawyer and Blood Clot Death Lawyer Jason S. Coomer

As the $880 Billion per year global pharmaceutical market continues to expand, many drug companies are looking to make huge profits by selling contraceptives in the rapidly growing multi-billion birth control market.  Many of these drug companies are aggressively marketing contraceptives that increase a woman's risk of suffering a heart attack death, blood clot death, or debilitating stroke.

NuvaRing Is a Once A Month Birth Control That Has Been Linked To An Increased Risk That The Woman Using The Contraceptive Will Suffer a Heart Attack Death, Blood Clot Death, or Debilitating Stroke by Texas NuvaRing Heart Attack and Blood Clot Death Lawyer Jason S. Coomer

The contraceptive, NuvaRing, is a once a month birth control device that has been scientifically linked to an increased risk that the woman using the contraceptive will suffer a heart attack death, blood clot death, or debilitating stroke.  Several NuvaRing Heart Attack Death and Blood Clot Death Lawyers have filed and are currently filing NuvaRing Lawsuits alleging that Merck, the maker of NuvaRing failed to adequately warn women and their doctors about the risks associated with the NuvaRing device.  For more information on NuvaRing Lawsuits, Texas NuvaRing Lawsuits, and International NuvaRing Lawsuits, please  please feel free to contact Texas NuvaRing Heart Attack Death Lawyer and NuvaRing Blood Clot Death Lawyer Jason Coomer or go to the following web page: NuvaRing Heart Attack Death Lawsuit, NuvaRing Blood Clot Death Lawsuit, and NuvaRing Stroke Lawsuit Information.


The Birth Control Medications Yaz, Beyaz, Yasmin, and Ocella Have Been Linked To An Increased Health Risk of Sudden Death, Cardiovascular Problems, Blood Clots, Strokes and Heart Attacks by Texas Pulmonary Embolism Yaz Lawyer, Texas Pulmonary Embolism Yasmin Lawyer, and Texas Pulmonary Embolism Ocella Lawyer Jason S. Coomer
Other hormonal contraceptives including YAZ, Ocella, Beyaz, and Yasmin are also the subject of lawsuits alleging that Bayer HealthCare Pharmaceuticals, Inc. has run false marketing campaigns that were misleading regarding the potential health risks that have been associated with these oral contraceptives.  These lawsuits are also alleging that these drugs cause an increased risk that the woman using the contraceptive will suffer a heart attack death, blood clot death, or debilitating stroke.    
For more information on YAZ, Ocella, Beyaz, Yasmin, and other hormonal contraceptive lawsuits, please feel free to  contact Texas Birth Control Heart Attack, Stroke, and Blood Clot Death Lawyer Jason S. Coomer or go to the following web page: YAZ Heart Attack Death Lawsuit, YAZ Blood Clot Death Lawsuit, and YAZ Stroke Lawsuit Information.

Sunday, July 8, 2012

Fatal Blood Clots Can Be Caused By Defective Drugs and Medical Devices by Texas Defective Drug Blood Clot Death Lawyer and Texas Defective Medical Device Fatal Blood Clot Lawyer Jason S. Coomer

Fatal Blood Clots Can Be Caused By Defective Drugs and Defective Medical Devices by Texas Defective Drug Blood Clot Death Lawyer and Texas Defective Medical Device Fatal Blood Clot Lawyer Jason S. Coomer

Fatal blood clots are on the rise as drug companies and medical device manufacturers have aggressively marketed drugs and medical devices that can cause an increased risk of blood clots resulting in heart attacks, strokes, and pulmonary embolisms.  Person using hormonal contraceptives and medical devices that increase their risk of a fatal blood clot should be aware of the potential danger and warning signs of a blood clot.  If you have lost someone from a fatal blood clot or have experienced a serious injury from a blood clot related to a defective drug or medical device, it is important to make sure the adverse event is reported to the prescribing doctor and FDA.

The Birth Control Contraceptive, NuvaRing, Has Been Linked To An Increased Health Risk of Fatal Blood Clots by Texas NuvaRing Blood Clot Lawyer Jason S. Coomer
The hormonal long lasting contraceptive, NuvaRing, is the subject of several lawsuits alleging that the once a month birth contraceptive may cause fatal blood clots and other serious health problems for women that are using this medical device.  For more information on NuvaRing Blood Clot Lawsuits, please go to the following web page: NuvaRing Fatal Blood Clot Lawsuits and NuvaRing Death Lawsuits.

The Birth Control Medications Yaz, Beyaz, Yasmin, and Ocella Have Been Linked To An Increased Health Risk of Sudden Death, Cardiovascular Problems, Blood Clots, Strokes and Heart Attacks by Texas Pulmonary Embolism Yaz Lawyer, Texas Pulmonary Embolism Yasmin Lawyer, and Texas Pulmonary Embolism Ocella Lawyer Jason S. Coomer
YAZ, Ocella, Beyaz, and Yasmin are oral hormonal contraceptives have been aggressively marketed to young women despite research that indicates that the drugs may cause an increased risk of fatal blood clots. For more information on YAZ, Ocella, Beyaz, Yasmin, and other hormonal contraceptive  blood clot lawsuits, please go to the following web page: YAZ Blood Clot Lawsuits, Yasmin Blood Clot Lawsuits, Ocella Blood Clot Lawsuits, Beyaz Blood Clot Lawsuits and Birth Control Blood Clot Death Lawsuits.

Defective Inferior Vena Cava Filters Can Break Apart, Perforate, and Migrate in a Person's Body Causing Fatal Blood Clots and Embolisms by Texas IVC Filter Blood Clot Lawyer Jason S. Coomer
Defective Inferior Vena Cava Filters can migrate, fracture, and break apart inside a person causing fatal blood clots and embolisms.  The FDA recommends that persons with inferior vena cava filters (IVC filters) should contact their doctors regarding removal of the devices.  For more information on IVC Filter Blood Clot Lawsuits, please feel free to go to the following web page: Texas IVC Filter Blood Clot Lawyer and Inferior Vena Cava Filter Failure Embolism Lawyer,

Friday, July 6, 2012

Heart Doctors Concerned Over Pradaxa and Xarelto

 Evidence of the harm caused by the blood thinning drugs Pradaxa and Xarelto continues to grow.  How safe are these drugs and are they really preferable to Wafarin?  Doctors warn that neither of these new drugs has a known antidote for excessive bleeding issues, but Wafarin does.


http://www.huffingtonpost.com/2012/06/14/pradaxa-xarelto-blood-thinner-doctors-heart_n_1595971.html

 "They say that real world use of Pradaxa and Xarelto, which do not require regular blood monitoring or frequent doctor follow-up, raises concerns about the risk of stroke, serious bleeding and blood clots if not taken properly, particularly in patients with poor kidney function.

The nonprofit Institute for Safe Medication Practices estimated last month that 542 reports of deaths associated with Pradaxa were reported to the FDA in 2011, topping all other medicines, including warfarin, with 72 deaths. Adverse event reports on Xarelto were not available."

Tuesday, June 26, 2012

Hip Maker Discussed Failures

More details emerge surrounding Johnson and Johnson' Depuy hip replacement failures.  How aware was the company that their product was unsafe?

 http://www.nytimes.com/2012/02/22/business/flawed-depuy-hip-implant-had-early-fda-notice.html?pagewanted=all

"Throughout the episode, DePuy blamed orthopedic surgeons for the model’s failures, saying that doctors were not positioning a component properly. But the clinical findings rejected by the F.D.A. came from A.S.R. studies run by surgeons hand-picked by DePuy, including some who had developed the implant and received royalties or consulting fees in connection with it."

Wednesday, June 20, 2012

Popular diabetes drugs may raise pancreatic cancer risk, study suggests

 People with type 2 diabetes taking the drugs Januvia or Byetta might have an increased risk of developing pancreatitis and pancreatic cancer, a preliminary study suggests. 
The study also found that Byetta (exenatide) may raise the risk of thyroid cancer.
Although the links aren't conclusive, they merit further investigation, the researchers noted.
"We have raised concern that there may be a link, but we haven't confirmed it," said lead researcher Dr. Peter Butler, director of the Larry L. Hillblom Islet Research Center at the University of California, Los Angeles. "We need to do more work to figure out whether this is real or not."
Both drugs help control blood sugar levels by encouraging production of a hormone called glucagon-like peptide 1 (GLP-1).
Januvia (sitagliptin) and Byetta, an injectable drug, are a new way of treating type 2 diabetes, and they potentially have advantages over older medications, Butler said. But, because these drugs are new, they're "the ones we know least about," he said. "When new drugs come out, the long-term side effects of these drugs are not well understood."
For the study, recently published in the journal Gastroenterology, Butler's team used 2004-2009 information in the U.S. Food and Drug Administration's database on adverse events, which are reported by doctors whose patients use these drugs.
When compared to other treatments, the researchers found a sixfold increase of reported cases of pancreatitis (inflammation of the pancreas) linked to patients taking Januvia or Byetta; a 2.9-fold increase in reported cases of pancreatic cancer among those taking Byetta and a 2.7-fold increase of reported pancreatic cancers among Januvia users.
In addition, they also noted an increase in reported cases of thyroid cancer with Byetta.

 http://www.usatoday.com/news/health/medical/health/medical/story/2011-09-23/Popular-diabetes-drugs-may-raise-pancreatic-cancer-risk-study-suggests/50531776/1